Ursoval — ursodeoxycholic acid of Ukrainian production from Italian raw materials for the treatment of patients with liver and biliary tract diseases.

Trade name: Ursoval

Composition:

• active ingredient: ursodeoxycholic acid;
• 1 capsule contains 250 mg of ursodeoxycholic acid;
• excipients: corn starch, pregelatinized corn starch, hydroxypropylcellulose, colloidal anhydrous silicon dioxide, magnesium stearate;
• composition of the hard gelatin capsule: gelatin, titanium dioxide (E 171).

Pharmacotherapeutic group:

Drugs used for the treatment of the liver and biliary tract. Drugs used in biliary pathology.

ATX code A05A A02.

Drugs used in liver diseases, lipotropic substances.

ATX code A05B.

Indications:

For the dissolution of radio-negative cholesterol gallstones not exceeding 15 mm in diameter in patients with a functioning gallbladder, despite the presence of gallstone(s) in it.

For the treatment of biliary reflux gastritis.

For the symptomatic treatment of primary biliary cirrhosis (PBC) in the absence of decompensated liver cirrhosis.

For the treatment of hepatobiliary disorders in cystic fibrosis in children aged 6 to 18 years.

Packaging: 10 capsules in a blister, 5 or 10 blisters in a cardboard pack.

Release category: By prescription.